M C27 (Clopidogrel bisulfate 75 mg (base))
Pill imprint M C27 has been identified as Clopidogrel bisulfate 75 mg (base).
Clopidogrel is used in the treatment of ischemic stroke; transient ischemic attack; heart attack; ischemic stroke, prophylaxis; peripheral arterial disease (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- M C27
- 75 mg (base)
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0557||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about clopidogrel
- Other brands: Plavix
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.